ImmunoPrecise Increases Financing to $2.3 Million and Makes Payment in Respect of Deferred Purchase Price for IPA Europe and Immulease

Stock Information for Immunoprecise Antibodies Ltd.

Loading

Please wait while we load your information from QuoteMedia.